Health
WHO Calls for Global Solidarity to Stop Monkeypox
By Adedapo Adesanya
The rapidly spreading Monkeypox outbreak can be stopped, the World Health Organisation (WHO) said on Tuesday, “with the right strategies in the right groups”.
However, there is no time as “we all need to pull together to make that happen”, warned Dr Rosamund Lewis, WHO Technical Lead on Monkeypox, during a regular press briefing at the world health authority headquarters in Geneva, Switzerland.
This is coming after WHO’s Director-General, Mr Tedros Adhanom Ghebreyesus, declared the spread of the virus to be a public health emergency of international concern (PHEIC), the organization’s highest level of alert.
“Through this, we hope to enhance coordination, cooperation of countries and all stakeholders, as well as global solidarity,” Dr Lewis said.
WHO assessed the risk posed to public health by Monkeypox in the European region as high, but at the global level as moderate. With “other regions not at the moment as severely affected”, declaring a PHEIC was necessary “to ensure the outbreak was stopped as soon as possible”.
This year, there have been more than 16,000 confirmed cases of monkeypox in more than 75 countries but Dr Lewis said the real number was probably higher.
She pointed out that in the Democratic Republic of the Congo, several thousand cases were suspected, but testing facilities are limited.
“The global dashboard did not include suspected cases,” she said.
First identified in monkeys, the virus is transmitted chiefly through close contact with an infected person (you can read Business Post’s detailed explainer on the disease, here).
Until this year, the virus which causes Monkeypox has rarely spread outside Africa where it is endemic but reports of a handful of cases in Britain in early May signalled that the outbreak had moved into Europe.
Dr Lewis pointed out that stigma and discrimination must be avoided, as that would harm the response to the disease.
“At the moment the outbreak is still concentrated in groups of men who have sex with men in some countries, but that is not the case everywhere,” she said. “It is really important to appreciate also that stigma and discrimination can be very damaging and as dangerous as any virus itself,” she said.
Monkeypox could cause a range of signs and symptoms, including painful sores. Some people developed serious symptoms that need care in a health facility. Those at higher risk for severe disease or complications include pregnant women, children, and immunocompromised persons.
The WHO Lead said WHO was working with the Member States and the European Union on releasing vaccines, and with partners to determine a global coordination mechanism. She emphasized that mass vaccination was not required, but the WHO had recommended post-exposure vaccination.
Vaccine sharing should be done according to public health needs, country by country, and location by location as not all regions had the same epidemiology, she explained.
Dr Lewis stressed that countries with manufacturing capacity for smallpox and Monkeypox diagnostics, vaccines or therapeutics should increase production.
Countries and manufacturers should work with WHO to ensure they are made available based on public health needs, solidarity, and at a reasonable cost to countries where they were most needed.
The specialist explained that some 16.4 million vaccines were currently available in bulk but needed to be finished. The countries currently producing vaccines are Denmark, Japan, and the United States.
She reminded that the current recommendation for persons with Monkeypox was to isolate and not travel until they recovered; contact cases should be checking their temperature and monitoring possible other symptoms for the period of 9 to 21 days.
“When someone is vaccinated it takes several weeks for the immune response to be generated by the body”, she said.
According to Dr Lewis, the name “Monkeypox” is already present in the International Classification of Diseases, and a process had to be followed in order to potentially change its name.
By Modupe Gbadeyanka
The Lagos State government has kicked off an initiative to ensure that every newborn is screened for Sickle Cell Disease within 48 to 72 hours after birth using a simple heel-prick test.
It was gathered that babies identified as being at risk will immediately be placed on preventive care while awaiting confirmatory testing.
The Head of the Haematology Department at the Alimosho General Hospital, Dr Olubukola Orolu, revealed that an estimated 150,000 babies are born annually with Sickle Cell Disease in Nigeria, giving the country one of the highest SCD burdens globally.
She, however, applauded the Lagos State Government and the Clinton Health Access Initiative (CHAI) for introducing the state-wide newborn screening programme, describing it as a major step towards reducing childhood deaths associated with the disease.
The commencement of this scheme coincides with the 2026 World Sickle Cell Day, themed Young Voices Rising for Sickle Cell Disease – Closing the Survival Gap: Equity in Sickle Cell Disease.
It highlights the importance of listening to the experiences and aspirations of young people living with Sickle Cell Disease.
Mrs Orolu noted that SCD warriors are increasingly breaking barriers as advocates, leaders, students and change-makers, adding that their voices have continued to reshape the narrative through advocacy for equitable, patient-centred healthcare, self-care and experience sharing.
She, therefore, called for equal access to quality healthcare, survival opportunities and dignity for everyone living with Sickle Cell Disease.
Also commenting, the chief executive of Alimosho General Hospital, Dr Akinyele Akinlade, described Sickle Cell Disease as an inherited blood disorder that is not contagious, noting that individuals living with the condition are more susceptible to infections.
He advised SCD warriors to stay well hydrated, avoid stress, and protect themselves from extreme cold or heat, as these are common triggers of sickle cell crises, adding that these preventive measures can significantly reduce the frequency and severity of crises.
One of the participants, Ms Borokini Zainab, an SCD warrior and student nurse, expressed appreciation to the organisers for the enlightenment programme.
Sharing her personal journey, she spoke about the challenges of balancing recurrent pain crises with her academic pursuits and personal life. Despite moments of frustration, she encouraged fellow warriors not to lose hope.
“Don’t let sickle cell put you down. Be encouraged from within. Don’t let your dreams be shattered because of this,” she said, adding that her personal experience with Sickle Cell Disease inspired her to pursue a career in nursing so she could support others living with the condition.
By Aduragbemi Omiyale
A 12-week health-tech incubation programme tailored for early-stage founders in Nigeria has been introduced by an innovation and venture-building platform, Evon Labs.
This initiative, known as HealthX Catalyst, will help participants to create scalable, investable solutions for Africa’s urgent healthcare issues.
The programme is underway, with 12 selected founders nearing the final weeks of intensive incubation, ending with a Demo Day on June 24, 2026, at the UNDP innovation centre in Lagos, where the small business owners will present their solutions to an audience of investors, healthcare leaders, development organisations, and technology partners.
The initiative selects early-stage healthcare founders and immerses them in a structured 12-week development process. Throughout this period, participants receive personalised and group mentorship from seasoned professionals across the healthcare, technology, and business sectors.
They also receive structured support for startup development, including refining business models, developing value propositions, and validating markets.
Additionally, participants gain access to a network of healthcare practitioners, sector experts, and industry leaders, along with targeted investment-readiness assistance to prepare them to engage with investors and strategic partners after the programme.
The result is a cohort of founders who move through the programme not simply with a refined pitch, but with a validated business model, a stronger professional network, and a clear pathway to growth.
To accelerate the most promising solutions beyond the programme, monetary grants will be awarded to the top three founders to support product development, pilot implementation, market validation, and early-stage scaling.
It was learned that HealthX Catalyst was developed in response to a structural gap in the African health-tech ecosystem.
Across the continent, a growing number of entrepreneurs are building solutions to healthcare problems from access and diagnostics to service delivery and health data infrastructure. Yet many of these early-stage ideas fail to progress beyond concept, not for lack of vision, but for lack of structured support: mentorship, startup development frameworks, industry access, and early-stage funding pathways. HealthX Catalyst was built to provide exactly that.
“Africa does not have a shortage of healthcare innovators. What it has lacked is the infrastructure to turn its ideas into sustainable businesses. HealthX Catalyst is that infrastructure, a serious, structured programme designed to take founders from early-stage ideas to investable startups.
“What we are seeing from this first cohort is exactly what we set out to create: founders who are not just building products, but building businesses that can scale and create lasting impact,” the founder of Evon Labs, Ms Isioma Udeozo, said of the unveiling of HealthX Catalyst.
The partners of the programme are the United Nations Development Programme (UNDP), Odua Investment Company Limited (OICL), Washington University of St Louis, Missouri, Lagos State Employment Trust Fund (LSETF), and Brooks Insights.
By Aduragbemi Omiyale
The sum of $250,000 in humanitarian funding is to be provided by Binance to support the frontline response to the ongoing Ebola disease outbreak in the Democratic Republic of Congo (DRC) and Uganda.
The cryptocurrency exchange said the funds would be used to enable rapid response in high-risk and underserved areas, where access to healthcare infrastructure, protective resources, and timely public health information remains limited.
The money will be shared equally between the Uganda Red Cross Society and Doctors Without Borders / Médecins Sans Frontières (MSF), supporting urgent interventions in affected and high-risk communities.
Binance’s contribution will help strengthen emergency medical care and treatment, community awareness and prevention campaigns, contact tracing and containment support, and the provision of sanitation supplies and protective equipment for frontline workers.
By supporting both immediate response activities and preventative education, Binance aims to contribute to reducing transmission and strengthening community resilience.
“Communities across Africa continue to show extraordinary resilience in the face of complex challenges, but frontline responders should not have to face crises like this alone,” the co-chief executive of Binance, Mr Richard Teng, said.
“The teams working to contain the Ebola disease outbreak are delivering vital, life-saving support under incredibly difficult conditions.
“We are proud to support both the Uganda Red Cross Society and Doctors Without Borders as they work to protect vulnerable populations, strengthen local response efforts, and deliver urgent care where it is needed most,” he added.
Also commenting, the Secretary General for the Uganda Red Cross Society, Mr Robert Kwesiga, said, “Strong partnerships are essential during public health emergencies since we are not able to manage the outbreak alone.
“The support from Binance comes in so timely and handy, and will help us respond more rapidly, reach more at-risk communities, and reinforce the frontline services needed to help contain the outbreak and save lives.”
The MSF Emergency Programme Manager, Trish Newport, while speaking on the initiative, said, “The number of cases and deaths we are seeing in such a short timeframe, combined with the spread across several health zones and now across the border, is extremely concerning. In Ituri, many people already struggle to access healthcare and live with ongoing insecurity, making rapid action critical to prevent the outbreak from escalating further.”
Caused by the Bundibugyo virus, for which there is no approved vaccine or treatment, this Ebola disease outbreak has placed acute pressure on already fragile health systems in eastern DRC and the wider region.
Local authorities, international agencies, and humanitarian organisations are racing to contain it and protect affected communities.
Binance’s support is intended to reinforce these efforts at a critical moment. It reflects the company’s broader commitment to supporting communities across Africa through programmes focused on education, financial inclusion, digital skills development, and community empowerment.
In this case, Binance is extending that commitment to urgent humanitarian and public health needs by working alongside trusted organisations with deep frontline expertise.
-
Feature/OPED6 years agoDavos was Different this year
-
Travel/Tourism10 years ago
Lagos Seals Western Lodge Hotel In Ikorodu
-
Showbiz3 years agoEstranged Lover Releases Videos of Empress Njamah Bathing
-
Banking8 years agoSort Codes of GTBank Branches in Nigeria
-
Economy3 years agoSubsidy Removal: CNG at N130 Per Litre Cheaper Than Petrol—IPMAN
-
Banking3 years agoSort Codes of UBA Branches in Nigeria
-
Banking3 years agoFirst Bank Announces Planned Downtime
-
Sports3 years agoHighest Paid Nigerian Footballer – How Much Do Nigerian Footballers Earn